dc.relation.reference | Ader E , Felten DL , Cohen N , editors. Psychoneuroimmunology 2001. 3rd edition. San Diego: Academic Press.
al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997 ;15:277-84.
Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America. 1995 ;92(23): 10599-603.
Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Research 1979;39: 1447-1454.
Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 1991;11: 2499.
Antoni MH. Psychoneuroimmunology and cancer: fact or fiction? European Journal of Cancer 1999; 35A: 1603-1607.
Ashraf J, Thompson EB. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Molecular Endocrinology 1993;7: 631–642
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of I kB synthesis. Science 1995;270: 286-290,.
Baringo M. A life-death balance within the cell. Science 1996;274: 724.
Beato M, Chavez S, Truss, M. Transcriptional regulation by steroid hormones. Steroids 1996;61: 240–251.
Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83: 851-857.
Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Research 1985;45: 4206-4214.
Beck CA, Estes PA, Bona BJ, Muro-Cacho CA, Nordeen SK, Edwards DP. The steroid antagonist RU486 exerts different effects on the glucocorticoids and progesterone receptors. Endocrinology 1993;133: 728-740.
Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274: 782-784.
Benckhuijsen C, Osman AM, Hillebrand MJ, Smets LA. Glucocorticoid effect on melphalan cytotoxicity, cell-cycle position, cell size, and [3H]uridine incorporation in one of three human melanoma cell lines. Cancer Research 1987;47: 4814-4820 .
Bertoncini CR, Meneghini R. DNA strand breaks produced by oxidative stress in mammalian cells exhibit 3'-phosphoglycolate termini. Nucleic Acids Research., 1995;23: 2995-3002.
Bloomfield CD, Smith KA, Peterson BA, Munck A. Glucocorticoid receptors in adult acute lymphoblastic leukemia. Cancer Research 1981;41: 4857-4860.
Bourgeois S, Newby RF. Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 1977;11: 423-430.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976;72: 248-254.
Brady ME, Sartiano GP, Rosenblum SL, Zaglama NE, Bauguess CT. The pharmacokinetics of single high doses of dexamethasone. European Journal of Clinical Pharmacology 1987;32: 593-596.
Briehl MM, Flomerfelt FA, Wu XP, Miesfeld RL. Transcriptional analyses of steroid-regulated gene networks. Molecular Endocrinology 1990;4: 287-294.
Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H. Glucocorticoid-mediated repression of NF-kB activity in endothelial cells does not involve induction of IkB synthesis. Journal of Biological Chemistry 1996;271: 19612-19616.
Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treatment Reports. 1985; 69: 751-754.
Burnstein KL, Jewell CM, Sar M, Cidlowski JA. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms. Molecular Endocrinology 1994;8: 1764-1773.
Buttgereit F, Saag KG, Cutolo M, da Silva JA, Bijlsma JW. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2005;34: 14-21.
Caldenhoven, E., Liden, J., Wissink, S., Van der Stolpe, A., Raaijmarkers, J., and Koenderman, L. Negative crosstalk between RelA and the glucocorticoid receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Molecular Endocrinology 1995;9: 401-412.
Cao TM, Negrin RS, Stockerl-Goldstein KE, Johnston LJ, Shizuru JA, Taylor TL, Rizk NW, Wong RM, Blume KG, Hu WW. Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation 2000;6: 387-394.
Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research 1987;47: 936-942.
Cato AC, Wade E Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996;18: 317-378.
Cha HH, Cram EJ, Wang EC, Huang AJ, Kasler HG, Firestone GL. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells. Journal of Biological Chemistry 1998;73: 1998-2007.
Chang TC, Hung MW, Jiang SY, Chu JT, Chu LL, Tsai LC. Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression. FEBS Letters 1997;415: 11-15.
Chang TC, Tsai LC, Hung MW, Chu LL, Chu JT, Chen YC. Effects of transcription and translation inhibitors on a human gastric carcinoma cell line. Potential role of Bcl-X(S) in apoptosis triggered by these inhibitors. Biochemical Pharmacology 1997;53: 969-977.
Chapman MS, Askew DJ, Kuscuoglu U, Miesfelt RL. Transcritional control of steroid-regulated apoptosis in murine thymoma cells. Molecular Endocrinology 1996;10: 967-978.
Chaudhuri PK, Thomas PA, Walker MJ, Briele HA, Das Gupta TK, Beattie CW. Steroid receptors in human lung cancer cytosols. Cancer Letters 1982;16: 327-332.
Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proceedings of the National Academy Sciences of the United States of America 1997;94: 10057-10062.
Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, Cheng AL. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochemical Pharmacology. 2002;63: 1709-1716.
Coia LR. Esophageal preservation--the management of esophageal cancer with concurrent radiation and chemotherapy. Endoscopy. 1993; 5:664-9.
De Bosscher K, Van den Berghe W, Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. Journal of Neuroimmunology. 2000;109: 16-22.
De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. Glucocorticoids repress NF- B-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proceedings of the National Academy Sciences of the United States of America 2000;97: 3919-3924.
Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990;249: 1266-1272.
DiDonato J. Mercurio F. Rosette C. Wu-Li J. Suyang H. Ghosh S. Karin M. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Molecular and Cellular Biology. 1996; 16(4): 1295-304.
Dieken ES, Meese EU, Miesfeld RL. nti glucocorticoid receptor transcripts lack sequences encoding the amino-terminal transcriptional modulatory domain. Molecular and Cellular Biology. 1990;10: 4574-4581.
Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, Stallcup MR. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Molecular Endocrinology 1998;12(2): 302-13.
Dumont A, Hehner SP, Schmitz ML, Gustafsson JÅ, Liden J, Okret S, van der Saag PT, Wissink S, van der Burg B, Herrlich P, Haegeman G, De Bosscher K, Fiers W. Cross-talk between steroids and NF-kB: what language? Trends in Biochemical Sciences 1998;23: 233–235.
Eggert M, Mows CC, Tripier D, Arnold R, Michel J, Nickel J, Schmidt S, Beato M, Renkawitz R. A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. Journal of Biological Chemistry 1995;270(51): 30755-9.
Frankfurt O, Rosen ST. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Current Opinion in Oncology 2004;16: 553-563.
Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug Reactions and Toxicological Reviews 1996;15: 203-206.
Friedberg EC, Walker GC, Siede W. DNA repair and mutagenesis. ASM Press: Washington D.C., 1995; 14-19.
Fryer CJ, Archer TK. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 1998;393(6680): 88-91.
Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, Mizokami A, Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. Journal of Biological Chemistry 1999;274(12): 8316-21.
Gametchu B, Chen F, Sackey F, Powell C, Watson CS. Plasma membrane-resident glucocorticoid receptors in rodent lymphoma and human leukemia models. Steroids 1999;64: 107-119.
Garcia-del-Muro X, Vadell C, Perez Manga G, Bover I, Rifa J, Beltran M, Barros MM, Germa JR, Fabregat X, Moreno V, Salvador A, Viladiu P. Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis. European Journal of Cancer 1998; 34: 193-195.
Gascoyne DM, Kypta RM, Vivanco MM. Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. Journal of Biological Chemistry 2003;278: 18022-18029.
Gassler N, Zhang C, Wenger T, Schnabel PA, Dienemann H, Debatin KM, Mattern J, Herr I. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. British Journal of Cancer 2005;28: 1084-1088.
Gehring U, Mugele K, Ulrich J. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Molecular and Cellular Endocrinology 1984;36: 107-113.
Gershanovich M, Chaudri HA, Campos D, Lurie H, Bonaventura A, Jeffrey M, Buzzi F, Bodrogi I, Ludwig H, Reichardt P, O'Higgins N, Romieu G, Friederich P, Lassus M. Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3). Annals of Oncology. 1998;9: 639-645.
Giguere V, Hollenberg SM, Rosenfeld GM, Evans RM. Functional domains of the human glucocorticoid receptor. Cell 1986;46: 645-652.
Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. Journal of Molecular Medicine 1998;76: 480–489 .
Greenberg AK, Hu J, Basu S, Hay J, Reibman J, Yie TA, Tchou-Wong KM, Rom WN, Lee TC. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. American Journal of Respiratory Cell and Molecular Biology 2002;27: 320-328.
Gustafsson J, Carlstedt-Duke J, Poellinger L, Okret S, Wikstrom A, Bronnegard M, Gillner M, Dong Y, Fuxe K, Cintra A, Harfstrand A, Agnati L. Biochemistry, molecular biology and physiology of the glucocorticoid receptor. Endocrine Reviews. 1987;8: 185-234.
Haid M. Steroid antiemesis may be harmful. The New England Journal of Medicine. 1981; 304: 1237.
Harmon JM, Thompson EB. Isolation and characterization of dexamethasone- resistant mutants from human lymphoid cell line CEM-CT. Molecular and Cellular Biology 1981;1: 512-521.
Harmon JM, Norman MR, Fowlkes BJ, Thompson EB. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. Journal of Cellular Physiology. 1979;98: 267-278.
Haskell CM. Antineoplastic agents. In: Haskell, CM, Break JS. Cancer Treatment (4th edition). Philadelphia: W. B. Saunders, 1995: 105-106.
Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO 1995;14: 452-460.
Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Research 2003;163: 3112-3120.
Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene, 2001;20: 2465-2475.
Herrstedt J, Aapro MS, Smyth JF, Del Favero A. Corticosteroids, dopamine antagonists and other drugs. Supportive Care in Cancer 1998; 6: 204-214.
Hollenberg SM., Evans R. M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 1988;55: 899-906.
Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318: 635-641.
Iversen HG, Hjort GH. The influence of corticoid steroids on the frequency of spleen metastases in patients with breast cancer. Acta Pathologica et Microbiologica Scandinavica 1958;44: 205-212.
Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P. Anti-tumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990;62: 1189-1204.
Kaiser U, Hofmann J, Schilli M, Wegmann B, Klotz U, Wedel S, Virmani AK, Wollmer E, Branscheid D, Gazdar AF, Havemann K. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. International Journal of Cancer 1996;67: 357-364.
Kang HY, Yeh S, Fujimoto N, Chang C. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. Journal of Biological Chemistry 1999;274(13): 8570-6.
King K, Cidlowski J. Cell cycle regulation and apoptosis. Annual Review of Physiology 1998;60: 601-617.
Kolb EA, Steinherz PG. A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. Leukemia. 2003;17: 1967-1972.
Legrand-Poels S, Bours V, Piret B, Pflaum M, Epe B, Rentier B, Piette J. Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damages. Journal of Biological Chemistry 1995;270: 6925-6934.
Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, Wang CC. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Laboratory Investigation 1993;68: 716-727.
Lin CT, Wong CI, Chan WY, Tzung KW, Ho JKC, Hsu MM, Chuang SM. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Laboratory Investigation 1990;62: 713-724.
Lindemeyer RG, Robertson NM, Litwack G. Glucocorticoid receptor monoclonal antibodies define the biological action of RU 38486 in intact B16 melanoma cells. Cancer Research 1990;50: 7985-7991.
Lippman ME, Yarbro GK, Leventhal BG. Clinical implications of glucocorticoid receptors in human leukemia. Cancer Research 1978;38: 4251-4256.
Liu SH, Otal-Brun M, Webb TE. Glucocorticoid receptors in human tumors. Cancer Letters 1980;10:269-275
Lu YS, Lien HC, Yeh PY, Yeh KH, Kuo ML, Kuo SH, Cheng AL. Effects of Glucocorticoids on the Growth and Chemosensitivity of Carcinoma Cells Are Heterogeneous and Require High Concentration of Functional Glucocorticoid Receptors. World Journal of Gastroenterology 2005;11: 6373-6380.
Maranzano E. Radiation-induced emesis: a problem with many open questions. Tumori 2001;87: 213-218.
Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. Journal of Clinical Oncology 2000;18: 3262-3272.
May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunology Today 1998;19(2), 80-88.
McEwan IJ, Wright APH, Gustafsson JÅ. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 1997;19: 153–160.
McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocrine Reviews 1999;20(3): 321-44.
McKenna NJ, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(20): 11697-702.
Micha JP, Rettenmaier MA, Dillman R, Fraser P, Birk C, Brown JV. Single-dose dexamethasone paclitaxel premedication. Gynecologic oncology 1998;69: 122-124.
Miesfeld RL. Molecular genetics of corticosteroid action. The American Review of Respiratory Disease 1990;141(2Pt2): S11-S17.
Miller GE, Cohen S, Rabin BS, Skoner DP, Doyle WJ. Personality and tonic cardiovascular, neuroendocrine, and immune parameters psychoneuroendocrinology and psychoneuroimmunology of cancer: plausible mechanisms worth pursuing? Brain, Behavior, and Immunity 2003;17 Suppl 1: 84-91.
Miyamoto H, Yeh S, Wilding G, Chang C. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proceedings of the National Academy of Sciences of the United States of America 1998;95(13): 7379-84.
Moalli PA, Rosen ST. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies. Leukemia and Lymphoma 1994;15: 363-374.
Moalli PA, Pillay S, Krett NL, Rosen ST. Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Research 1993;53: 3877-3879.
Moalli PA, Pillay S, Weiner D, Leikin R, Rosen ST. A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood 1992;79: 213-222.
Moilanen AM, Poukka H, Karvonen U, Hakli M, Janne OA, Palvimo JJ. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Molecular and Cellular Biology 1998;18(9): 5128-39.
Muchardt C, Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO 1993;12(11): 4279-90.
Muenstedt K, Borces D, Bohlmann MK, et al. Glucocorticoid administration in antiemetic therapy. Cancer 2004; 101:1696-1702.
Münstedt K, Müller H, Blauth-Eckmeyer E, Stenger K, Zygmunt M, Vahrson H. Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting. British Journal of Cancer 1999; 79: 637-639.
Naumann U, Durka S, Weller M. Dexamethasone-mediated protection from drug cytotoxicity: association with p21 WAF1/CIP1 protein accumulation? Oncogene 1998;17:1567-1575
Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Molecular and Cellular Biology 1999;19(2): 1182-9.
Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270(5240): 1354-7.
Ostlund Farrants AK, Blomquist P, Kwon H, Wrange O. Glucocorticoid
receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Molecular and Cellular Biology 1997;17(2): 895-905.
Pei L. Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. Journal of Biological Chemistry 1996;271: 20879-20884.
Perez EA. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting. The Cancer Journal from Scientific American 1998; 4: 72-77.
Piret B, Piette J. Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. Nucleic Acids Research 1996;24: 4242-4248.
Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. European Journal of Cancer and Clinical Oncology 1989;25: 1823-1829.
Powell CB, Mutch DG, Kao MS, Kao JW, Perry DL, Westphale E, Collins JL. Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic (NC) cell activity. Cancer. 1990; 65: 466-472.
Powers JH, Hillmann AG, Tang DC, Harmon JM. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and glucocorticoid-resistant human leukemic cells. Cancer Research 1993;53: 4059–4065.
Pui CH, Costlow ME. Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update. Leukemia Research 1986;10: 227-229 .
Pui CH, Dahl GV, Rivera G, Murphy SB, Costlow ME. The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leukemia Research 1984;8: 579-585.
Quinto I, Ruocco MR, Baldassarre F, Mallardo M, Dragonetti E, Scala G. The human immunodeficiency virus type 1 long terminal repeat is activated by monofunctional and bifunctional DNA alkylating agents in human lymphocytes. Journal of Biological Chemistry 1993;268: 26719-26724.
Ramalingam A, Hirai A, Thompson EA. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1. Molecular Endocrinology 1997;11: 577-586.
Ramos RA, Nishio Y, Maiyar AC, Simon KE, Ridder CC, Ge Y. Glucocorticoid-stimulated CCAAT/enhancer-binding protein α expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells. Molecular and Cellular Biology 1996;16: 5288-5301.
Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-k B and the glucocorticoid receptor. Proceedings of the National Academy Sciences of the United States of America 1994;91: 752-756.
Reichardt HM, Schutz G. Glucocorticoid signaling–multiple variations of a common theme. Molecular and Cellular Endocrinology 1998;146:1–6
Rogatsky I, Hittelman AB, Pearce D, Garabedian MJ. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Molecular and Cellular Biology 1999;19: 5036-5049.
Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Molecular and Cellular Biology 1997;17: 3181-3193.
Samuelsson MK, Pazirandeh A, Davani B, Okret S. p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells. Molecular Endocrinology 1999;13: 1811-1822.
Scheidereit C, Geisse S, Westphal HM, Beato M. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 1983;304: 749-752.
Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IkB α in mediation of immunosuppression by glucocorticoids. Science 1995;270: 283-286.
Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. a Characterization of mechanisms involved in transrepression of NF-kB by activated glucocorticoid receptors. Molecular Cell Biology 1995;15: 943-953.
Schwartzman RA, Cidlowski JA. Glucocorticoid-induced apoptosis of lymphoid cells. International Archives of Allergy and Immunology 1994;105: 347-354.
Segnitz B & Gehring U. Mechanism of action of a steroidal antiglucocorticoid in lymphoid cells. Journal of Biological Chemistry 1990;265: 2789-2796.
Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. The FASEB Iournal 1996;10: 709 - 720.
Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen. American Journal of Hematology 2003; 74: 46-51.
Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. Journal of Neurosurgery 2003; 98: 342-349.
Sherlock P, Hartmann WH. Adrenal steroids and the pattern of metastases of breast cancer. JAMA 1962;181: 313-317.
Shishodia S, Aggarwal BB. Nuclear factor-kappaB: a friend or a foe in cancer? Biochemical Pharmacology 2004;68: 1071-1080.
Smith RA, Lea RA, Curran JE, Weinstein SR, Griffiths LR Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue. Breast Cancer Research 2003;5:R9-12.
Soffietti R, Ruda R, Mutani R. Management of brain metastases. Journal of Neurology 2002;249: 1357-1369.
Staal FJ, Roederer M, Herzenberg LA & Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proceedings of the National Academy Sciences of the United States of America 1990;87: 9943-9947.
Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. Journal of Clinical Oncology 2001;19: 3066-3072.
The Italian Group of AntiCancer Research. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. New England Journal of Medicine 1995;332: 1–5.
The Italian Group of AntiCancer Research. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. New England Journal of Medicine 2000;342: 1554–1559.
Unlap T, Jope RS. Inhibition of NF-kB DNA binding activity by glucocorticoids in rat brain. Neuroscience Letters 1995;198: 41-44.
Urashima M, Chen BP, Chen S, Pinkus GS., Bronson RT, Dedera DA, Hoshi Y, Teoh G, Ogata A, Treon SP, Chauhan D, Anderson KC. The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood 1997;90: 754-765.
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappa B. Science 1996;274: 787-789.
Van der Burg B, Okret S, Liden J, Wissink S, Van der Saag PT, Gustafsson JA. Nuclear factor-kappa-B repression in anti-inflammation and immunosuppression by glucocorticoids. Trends in Endocrinology and Metabolism 1997;8: 152-157.
Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Molecular Endocrinology 1987;1: 68-74.
Wang CY, Mayo MW, Baldwin AS. TNF-alpha and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappa B. Science 1996;274:784-787.
Wang H, Li M, Rinehart JJ, Zhang R. Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clinical Cancer Research 2004;10: 1633-1644.
Wang CY, Mayo MW, Baldwin AS. TNF-alpha and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappa B. Science, 274: 784-787, 1996.
Weijtens O, Schoemaker RC, Cohen AF, Romijn FP, Lentjes EG, Van Rooij J. Dexamethasone concentration in vitreous and serum after oral administration. American Journal of Ophthalmology 1998;125: 673-679.
Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG, Evans RM. Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science (Wash. DC) 1985;228: 740-742.
Wells RJ, Mascaro K, Young PC, Cleary RE. Glucocorticoid receptors in the lymphoblasts of patients with glucocorticoid-resistant childhood acute lymphoblastic leukemia. The American Journal of Pediatric Hematology/Oncology 1981;3: 259-264.
Wirth MP, Froschermaier SE. The antiandrogen withdrawal syndrome. Urological Research 1997;25 Suppl 2: S67-71.
Wiseman LR, Spencer CM. Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer. Drugs and Aging 1997; 10: 473-485.
Wissink S, van Heerde EC, van der Burg B, van der Saag PT. A dual mechanism mediates regression of NF-kappa B activity by glucocorticoids. Molecular Endocrinology 1998;12: 355-363.
Wissink, S., van Heerde, E. C., Schmitz, M. L., Kalkhoven, E., van der Burg, B., and Baeuerle, P. A. Distinct domains of the Rel A NF-kappa B subunit are required for negative cross-talk an direct interaction with the glucocorticoid receptor. The Journal of Biological Chemistry 1997;272: 22278-22284.
Wolf J, Spear P, Yesner R, Patno ME. Nitrogen mustard and steroid hormones in treatment of inoperable bronchogenic carcinoma. The American Journal of Medicine 1960;29: 1008-1016.
Wolff JE, Denecke J, Jurgens H. Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. AntiCancer Research 1996;16: 805-809.
Wright AP, Zilliacus J, McEwan IJ, Dahlman-Wright K, Almlof T, Carlstedt-Duke J. Structure and function of the glucocorticoid receptor. The Journal of Steroid Biochemistry and Molecular Biology 1993;47: 11-19.
Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Research 2004;64: 1757-1764.
Wu W, Pew T, Zou M, Pang D, Conzen SD. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. Journal of Biological Chemistry 2005; 11: 4117-4124.
Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annual Review of Genetics 1985;19: 209-252.
Yang CH, Schneider E, Kuo ML, Volk EL, Rocch E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochemical Pharmacology 2000;60:831-837.
Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine 1999;11(2): 195-202.
Yeh S, Miyamoto H, Shima H, Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proceedings of the National Academy of Sciences of the United States of America 1998; 95(10): 5527-32.
Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 1992;258(5088): 1598-604. | en |